Sridivya Bhagavatula

Engaged in the exploration of Multiple Pathogen Serology, my research addresses a critical concern: over 50% of human infections often remain undiagnosed. Although sequencing-based methods excel in pathogen identification, their limited detection window and nucleic acids' stability challenges hinder unbiased estimations of pathogen prevalence. Recognizing this, serological assays emerge as an optimal solution for identifying circulating and prevalent pathogens within a given region.

Within this context, our team is dedicated to the development of the Multiple PATHogen Serology (M-PATHS) assay. This innovative approach aims to concurrently detect antibodies against over 25 pathogens, including viruses, bacteria, fungi, and more, prevalent in India. Utilizing a mere drop of blood, M-PATHS seeks to provide a comprehensive assessment of the burden and recent (as well as past) exposure to diverse pathogens among both the general population and healthcare workers.

As a dedicated researcher, my passion lies in unraveling the intricate interactions between viruses and their hosts, deciphering the immune responses at play, and comprehending how these dynamics culminate in diseases. Additionally, I am deeply intrigued by the latest advancements in virology and their potential applications in shaping new treatments and vaccines.